Pharmaceutical isolators act as a bulwark in the drug manufacturing pipeline, adhering to safety guidelines outlined by regulatory agencies. Market Research Future (MRFR) has published a report about the global pharmaceutical isolator market that expects a hike for this market at 7.86% CAGR (Compound Annual Growth Rate) between 2018 and 2023.

The indispensable factor that leads to the global pharmaceutical isolator market growth is the need to prevent the contamination of pharmaceuticals. Other important factors leading to the market growth are high sterility levels associated with the devices like drug manufacturing pipeline, integration of such devices to replace legacy filling machines adhering to latest safety protocols, low operational costs, investments in research and development (R&D), and increasing amalgamation of aseptic processing of toxic compounds.

Pharmaceutical Isolator Market– Segmentation

The global pharmaceutical isolator market has been segmented on the basis of application, end user, pressure, type, and lastly, region. The application-based segmentation segments this market into the aseptic filling, fluid dispensing, product containment, sampling/weighing/distribution, and others. Based on the end user, the market has been segmented into hospitals, pharmaceutical & biotechnology companies, and others. The pressure based segmentation covers positive and negative. By type, the market has been segmented into open isolator and closed isolator.

Latest Industry News

ATS Automation Tooling Systems Inc. (“ATS” or the “Company”), an industry-leading automation solutions provider, has signed a definitive agreement to acquire Comecer S.p.A. (“Comecer”), a leader in the design, engineering, manufacture and servicing of advanced aseptic containment and processing systems for the nuclear medicine and pharmaceutical industries. 19 DEC 2018

Bioquell has installed its 200th unit of Qube at a facility in Andover in the UK. Qube is the aseptic workstation of Bioquell. This high-performance isolator has been supplied to a major international pharmaceutical company. 23 NOV 2018

Pharmaceutical Isolator Market– Regional Analysis

The regional segmentation of the global pharmaceutical isolator market segments the market into regional markets namely The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas lead the global market because North America alone holds the potential anyway to be the biggest regional market. In this region, the market is growing due to the adoption of latest devices & systems, the high purchasing power of people, the presence of many key market players, and sharp rise noticed in numbers of biotechnology laboratories. By the end of forecast period, the market in the Americas is expected to grow at 8.08% CAGR, attaining the value of US $ 12,142.2 mn by 2023. The key country-specific markets in this region are USA and Canada. South America is a smaller market compared to North America as the purchasing power of people is low. However, Argentina and Brazil are two strong economies in this region that can emerge as big markets in the near future.

Europe is the second largest regional market. In this region, the market is growing due to the availability of government funding for research and development (R&D) activities, the presence of some key market players, and advanced medical facilities that are second only to North America. Remaining reasons for market growth are the same as those of North America. Due to the reasons same as the Americas, Western Europe is a bigger market than Eastern Europe. The most powerful economies in Europe that can lucrative markets are France, Germany, and the UK.

In the Asia Pacific region, pharmaceutical isolator market has been estimated to grow at 8.73% CAGR during the forecast period due to the booming pharmaceutical sector in China and India. Other factors contributing to the market growth are the presence of contract manufacturing organizations in these countries and demand for generic drugs. Other important country-specific markets in this region are Australia, Japan, and South Korea, followed by the remaining countries of the Asia Pacific region.

In the MEA region, the market is small and limited due to poor countries, lack of awareness, lack of advanced medical facilities, low standard of medical facilities, lack of education, lack of healthcare facilities, and most governments not considering healthcare a priority.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.